Inventor · disambiguated record
Arvind Rajpal
Also filed as: RAJPAL ARVIND
45 granted patents·32 pending applications·792 citations·filing 2005–2025
98Inventor score
Files withPFIZER20BRISTOL MYERS SQUIBB CO17RINAT NEUROSCIENCE CORP13FIVE PRIME THERAPEUTICS INC6ALLOGENE THERAPEUTICS INC3
Top patents by PatentIndex Score
77 records- 0198US8871908B2Antibodies specific for Trop-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2012·Granted Oct 28, 2014·86 cites·26 claims
- 0297US10138303B2Heterodimeric proteins and methods for producing and purifying themRINAT NEUROSCIENCE CORP·Filed 2016·Granted Nov 27, 2018·14 cites·9 claims
- 0397US7960515B2Binding molecules to the human OX40 receptorBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 14, 2011·205 cites·12 claims
- 0496US11814435B2Therapeutic antibodies and their usesPFIZER·Filed 2020·Granted Nov 14, 2023·5 cites·7 claims
- 0596US9969809B2Therapeutic antibodies and their usesPFIZER·Filed 2016·Granted May 15, 2018·44 cites·8 claims
- 0696US9399074B2Antibodies specific for trop-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2014·Granted Jul 26, 2016·19 cites·19 claims
- 0796US8236930B2Binding molecules to the human OX40 receptorMIN JING·Filed 2011·Granted Aug 7, 2012·85 cites·5 claims
- 0895US11155630B2Therapeutic antibodies and their usesPFIZER·Filed 2020·Granted Oct 26, 2021·3 cites·14 claims
- 0995US9527926B2Heterodimeric proteins and methods for producing and purifying themHO WEI-HSIEN·Filed 2011·Granted Dec 27, 2016·44 cites·10 claims
- 1095US9028824B2Binding molecules to the human OX40 receptorMIN JING·Filed 2012·Granted May 12, 2015·75 cites·22 claims
- 1194US10155037B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2015·Granted Dec 18, 2018·18 cites·45 claims
- 1294US9676871B2Engineered polypeptide conjugates and methods for making thereof using transglutaminaseSTROP PAVEL·Filed 2011·Granted Jun 13, 2017·40 cites·19 claims
- 1393US11213586B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 4, 2022·5 cites·14 claims
- 1493US9029515B2Anti-PCSK9 antibodies with pH dependent antigen bindingPONS JAUME·Filed 2011·Granted May 12, 2015·43 cites·4 claims
- 1592US10294304B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2016·Granted May 21, 2019·16 cites·22 claims
- 1691US10793635B2Therapeutic antibodies and their usesPFIZER·Filed 2018·Granted Oct 6, 2020·4 cites·13 claims
- 1791US10653791B2Antibodies comprising modified heavy constant regionsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 19, 2020·10 cites·6 claims
- 1889US10040860B2Therapeutic antibodies and their usesPFIZER·Filed 2018·Granted Aug 7, 2018·6 cites·8 claims
- 1988US8710191B2Antibodies to CCR2GLADUE RONALD P·Filed 2009·Granted Apr 29, 2014·21 cites·11 claims
- 2088US7867494B2Anti-IgE antibodiesAMGEN FREMONT INC·Filed 2008·Granted Jan 11, 2011·30 cites·14 claims
- 2185US11014989B2Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapyCELLECTIS·Filed 2016·Granted May 25, 2021·2 cites·24 claims
- 2285US10660953B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2018·Granted May 26, 2020·2 cites·19 claims
- 2385US2024018252A1Therapeutic antibodies and their usesPFIZER·Filed 2023·Application pending·0 cites
- 2484US11072644B2Inhibitory chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2015·Granted Jul 27, 2021·2 cites·21 claims
- 2582US11312782B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2019·Granted Apr 26, 2022·1 cites·46 claims
- 2681US11623965B2Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 11, 2023·1 cites·11 claims
- 2781US11602525B2Antibody-drug conjugates with high drug loadingRINAT NEUROSCIENCE CORP·Filed 2015·Granted Mar 14, 2023·2 cites·17 claims
- 2881US11390689B2Heterodimeric proteins and methods for producing and purifying themRINAT NEUROSCIENCE CORP·Filed 2018·Granted Jul 19, 2022·1 cites·12 claims
- 2981US2025206822A1Antibodies Binding to Vista at Acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3080US12478674B2Ipilimumab variants with enhanced specificity for binding at low pHBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 25, 2025·1 cites·10 claims
- 3179US12195535B2Antibodies binding to VISTA at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2023·Granted Jan 14, 2025·0 cites·37 claims
- 3279US8188235B2Antibodies to IL-6 and their usesRAJPAL ARVIND·Filed 2009·Granted May 29, 2012·3 cites·10 claims
- 3378US10196452B2Binding molecules to the human OX40 receptorPFIZER·Filed 2017·Granted Feb 5, 2019·1 cites·16 claims
- 3478US2024360196A1Inhibitory chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3578US2022332850A1Heterodimeric proteins and methods for producing and purifying themRINAT NEUROSCIENCE CORP·Filed 2022·Application pending·0 cites
- 3677US12173069B2Antibodies binding to vista at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Dec 24, 2024·1 cites·28 claims
- 3776US10100114B2Antibodies specific for TROP-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2016·Granted Oct 16, 2018·1 cites·9 claims
- 3876US2024228653A1PSGL-1 Antagonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3976US2022249657A1Anti-pd-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2022·Application pending·0 cites
- 4076US2022002428A1Binding molecules to the human ox40 receptorPFIZER·Filed 2021·Application pending·0 cites
- 4175US2025129166A1Antibodies Binding to Vista at Acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4274US2024141059A1Antibodies comprising modified heavy constant regionsBRISTOL MAYERS SQUIBB COMPANY·Filed 2023·Application pending·0 cites
- 4374US2024228636A1mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLSCELLECTIS·Filed 2023·Application pending·0 cites
- 4473US11912776B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2022·Granted Feb 27, 2024·0 cites·24 claims
- 4571US2023295346A1Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 4671US2022175921A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 4770US11338035B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2020·Granted May 24, 2022·0 cites·15 claims
- 4870US9238691B2Nucleic acids encoding antibodies to CCR2PFIZER·Filed 2014·Granted Jan 19, 2016·1 cites·31 claims
- 4968US2022298258A1PSGL-1 Antagonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 5067US2021115159A1Engineered polypeptide conjugates and methods for making thereof using transglutaminasePFIZER·Filed 2020·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →